Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Skin Neoplasms 3Kasabach-Merritt Syndrome 2Kaposiform Hemangioendothelioma 2Waldenstrom Macroglobulinemia 1Renal Transplant Patients at High-risk for Skin Cancer 1Refractory Solid Tumors 1Peutz-Jeghers Syndrome 1Neoplasms, Plasma Cell 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leiomyoma 1Hereditary Sensory and Autonomic Neuropathies 1Hemangioma 1Angiomyolipoma 1

Interventions

ulipristal acetate 9Leuprolide 4Uterine Artery Embolization 3ulipristal 2Tranexamic Acid 2Letrozole 2Bupivacaine 2ferrous sulfate 1elagolix 1dienogest 1cetrorelix 1Vitamin B 6 1Uterine Myomectomy 1Sodium Chloride 1Sirolimus 1Saline Solution 1Rocuronium 1Pregabalin 1Oxytocin 1Naproxen 1Misoprostol 1Mifepristone 1Lidocaine 1Ibuprofen 1Goserelin 1Gonadotropin-Releasing Hormone 1DMAC2L protein, human 1Celecoxib 1Anesthetics, Local 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Leiomyoma × Sirolimus × Clear all
NCT03500367 2018-04-18

Efficacy and Safety of Rapamycin (Sirolimus) in the Treatment of Symptomatic Uterine Fibroids and Leiomyomatosis

Peking Union Medical College Hospital

Phase 4 Unknown
25 enrolled

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡